You are currently viewing a new version of our website. To view the old version click .

Advances in Fungal Infection

This special issue belongs to the section “Fungal Pathogenesis and Disease Control“.

Special Issue Information

Dear Colleagues,

The incidence of fungal infections has increased in recent decades, predominantly among immunosuppressed patients. Only four classes of antifungal drugs are currently used in clinical practice for treatment of invasive fungal infections. With treatment of patients with antifungal drugs, resistance is evolving in pathogenic fungi, which is an emerging concern worldwide. Candida glabrata resistance to echinocandins and azole resistance to Aspergillus spp. have been reported globally; these fungi cause infections with high mortality rates. In addition, the number of infections caused by emerging fungi that are resistant to the limited number of antifungal drugs is also rising. Identification of antifungal susceptibility for clinical fungal isolates affects the choice of antifungal drugs to be used and patients’ survival. The aim of this issue is to shed light on the epidemiology of antifungal resistance, the prevalence of emerging fungal infections, and new diagnostic approaches for identification and drug resistance fungi.

Dr. Nahid Kondori
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Fungi is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • invasive fungal infections
  • emerging fungal infection
  • antifungal resistance
  • new diagnostic approaches
  • antifungal susceptibility

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
J. Fungi - ISSN 2309-608X